Partner
Dr. Martin
Sperrle
Martin Sperrle is a partner at Latscha Schöllhorn Partner since 2014. He assists clients, in particular, start-ups, SMEs and universities, in the fields of biotechnology, pharmaceuticals, chemistry and medical engineering.
Martin Sperrle studied chemistry at the Universities of Tübingen and Pisa, completed his diploma thesis at the CNRS in Toulouse and received his PhD from the Swiss Federal Institute of Technology (ETH) in Zürich for research in the field of asymmetric catalysis and polymer chemistry. After a period of post-doctoral research at the Department of Organic Chemistry at Stanford University, he started his career in the field of industrial property at a patent law practice in Zürich in 1998. In 2001, he joined Cytos Biotechnology AG, an ETH Zürich start-up specializing in developing new classes of biopharmaceutical compounds and targeted immunotherapies for the treatment and prevention of chronic diseases. Being responsible for the firm’s IP, his tasks included developing and successfully implementing a global patent strategy and building up the patent portfolio, aspects of licensing, R&D collaborations and financial transactions as well as building up and heading an in-house IP and patent department. Martin Sperrle qualified as a European Patent Attorney in 2004 and is a qualified Swiss Patent Attorney. He was awarded his “Patent Litigation in Europe” diploma from Strasbourg University in 2007. He joined Latscha Schöllhorn Partner in August 2014.
Martin Sperrle was elected by the Swiss Parliament as non-permanent judge of the Swiss Federal Patent Court and is the Swiss delegate in the biotech committee of epi. He is a tutor at the Centre d´Etudes Internationales de la Propriété Industrielle (CEIPI) at Strasbourg University and was a lecturer at the MAS IP of the Zürich University of Applied Sciences (ZHAW) until its discontinuation (2007-2014). Martin Sperrle is a member of epi, VESPA, INGRES, AIPPI and LES.
Close